Cargando…

Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma

BACKGROUND: Pleural mesothelioma (MPM) is an aggressive malignancy with an average patient survival of only 10 months. Interestingly, about 5%–10% of the patients survive remarkably longer. Prior studies have suggested that the tumor immune microenvironment (TIME) has potential prognostic value in M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ollila, Hely, Mäyränpää, Mikko I., Paavolainen, Lassi, Paajanen, Juuso, Välimäki, Katja, Sutinen, Eva, Wolff, Henrik, Räsänen, Jari, Kallioniemi, Olli, Myllärniemi, Marjukka, Ilonen, Ilkka, Pellinen, Teijo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251441/ https://www.ncbi.nlm.nih.gov/pubmed/35795056 http://dx.doi.org/10.3389/fonc.2022.870352

Ejemplares similares

High tumor cell platelet‐derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma
por: Ollila, Hely, et al.
Publicado: (2021)

Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland
por: Torkki, Paulus, et al.
Publicado: (2021)

Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
por: Järvinen, Tommi, et al.
Publicado: (2021)

Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
por: Blom, Sami, et al.
Publicado: (2017)

Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study
por: Salo, Silja A. S., et al.
Publicado: (2020)

Combined epithelial marker analysis of tumour budding in stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2018)

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors
por: Chiaro, Jacopo, et al.
Publicado: (2023)

Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo
por: Li, Chang, et al.
Publicado: (2018)

Fibroblast as a critical stromal cell type determining prognosis in prostate cancer
por: Blom, Sami, et al.
Publicado: (2019)

Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models
por: Myllärniemi, Marjukka, et al.
Publicado: (2014)

General thoracic surgery in Finland, a perspective from the Helsinki University Hospital
por: Järvinen, Tommi, et al.
Publicado: (2022)

Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer
por: Pellinen, Teijo, et al.
Publicado: (2022)

The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma
por: Paajanen, Juuso, et al.
Publicado: (2022)

Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma
por: Yin, Miao, et al.
Publicado: (2017)

T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma
por: Leivonen, Suvi-Katri, et al.
Publicado: (2019)

PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma
por: Pollari, Marjukka, et al.
Publicado: (2018)

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2017)

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine
por: Koli, Katri, et al.
Publicado: (2016)

Association of tamoxifen resistance and lipid reprogramming in breast cancer
por: Hultsch, Susanne, et al.
Publicado: (2018)

Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients
por: Brück, Oscar, et al.
Publicado: (2021)

Primary intrahepatic malignant epithelioid mesothelioma
por: Perysinakis, Iraklis, et al.
Publicado: (2014)

E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
por: Bruun, Jarle, et al.
Publicado: (2021)

Patient features predicting long‐term survival and health‐related quality of life after radical surgery for non‐small cell lung cancer
por: Rauma, Ville, et al.
Publicado: (2016)

Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study
por: Järvinen, Tommi, et al.
Publicado: (2018)

Hand-sewn versus stapled anastomoses for esophagectomy: We will probably never know which is better
por: Järvinen, Tommi, et al.
Publicado: (2021)

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways
por: Saraswat, Mayank, et al.
Publicado: (2020)

Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL
por: Hohtari, Helena, et al.
Publicado: (2019)

Low skeletal muscle mass in stented esophageal cancer predicts poor survival: A retrospective observational study
por: Järvinen, Tommi, et al.
Publicado: (2018)

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
por: Hollmén, Maria, et al.
Publicado: (2023)

Histological comparison of malignant epithelioid mesothelioma in young and adult cattle
por: KAWASHIMA, Yuuto, et al.
Publicado: (2021)

Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma
por: Saddozai, Umair Ali Khan, et al.
Publicado: (2022)

Health-related quality of life after laparoscopic repair of giant paraesophageal hernia: how does recurrence in CT scan compare to clinical success?
por: Hietaniemi, Henriikka, et al.
Publicado: (2020)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer
por: Kudling, Tatiana V., et al.
Publicado: (2023)

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
por: Murumägi, Astrid, et al.
Publicado: (2022)

RhoA and vigilin are candidates for immunohistochemical markers for epithelioid malignant mesothelioma
por: Hiratsuka, Takuya, et al.
Publicado: (2022)

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study
por: Ghanim, B, et al.
Publicado: (2015)

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
por: Seppälä, Severi, et al.
Publicado: (2020)

Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity
por: Brcic, Luka, et al.
Publicado: (2021)

KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma
por: Vannucchi, Margherita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a67fhagd8rtf9grlbbalh8fvhh